Lipoproteins of human peripheral lymph

Area of Science:

• Lipid metabolism and transport
• Cardiovascular research
• Extravascular fluid dynamics

Background:

• Cholesterol concentration in peripheral lymph is approximately 10% of that in blood plasma.
• Very low density lipoproteins (VLDL) are virtually absent in lymph, likely due to endothelial permeability limitations.
• Apo B-containing lipoproteins in lymph primarily resemble plasma low density lipoproteins (LDL).

Purpose of the Study:

• To characterize the differences in lipoprotein composition between peripheral lymph and blood plasma.
• To investigate the distribution and characteristics of high-density lipoproteins (HDL) in lymph.
• To explore the implications for reverse cholesterol transport.

Main Methods:

• Analysis of lipoprotein concentrations and particle characteristics in peripheral lymph and blood plasma.
• Quantification of apolipoprotein A-I (apo A-I) and apolipoprotein A-II (apo A-II) in plasma and lymph.
• Microscopic examination of high-density lipoprotein (HDL) morphology in lymph.

Main Results:

• Peripheral lymph exhibits significantly lower cholesterol levels compared to plasma.
• Lymph contains minimal VLDL, with most apo B lipoproteins having LDL density.
• Apo A-I and apo A-II concentrations are lower in lymph, but a substantial portion is found extravascularly.
• Lymphatic HDL particles display a distinct square-packing structure, differing from plasma HDL.

Conclusions:

• Significant differences exist in lipoprotein profiles between plasma and peripheral lymph, particularly concerning HDL structure and distribution.
• The presence of large, uniquely structured HDL particles in lymph suggests a distinct role in extravascular lipid handling.
• Further research is needed to determine if increasing plasma apo A-I can enhance reverse cholesterol transport and offer clinical benefits.